A Real-World Study of Optimal Treatment with Anlotinib First-Line Therapy in Advanced Hepatocellular Carcinoma

A Real-World Study of Optimal Treatment with Anlotinib First-Line Therapy in Advanced Hepatocellular Carcinoma

Qingqing Li,1,* Tong Su,2,* Xu Zhang,3,* Yanfeng Pan,1,* Shengli Ma,4 Lu Zhang,4 Xianqiang Zhang,1 Xiaojuan Gao1 1Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou city, People’s Republic of China; 2Department of Medic...

Full description

Bibliographic Details
Main Authors: Li Q, Su T, Zhang X, Pan Y, Ma S, Zhang L, Gao X
Format: Article
Language:English
Published: Dove Medical Press 2022-10-01
Series:Cancer Management and Research
Subjects:
hepatocellular carcinoma
anlotinib
sequential therapy
real world
Online Access:https://www.dovepress.com/a-real-world-study-of-optimal-treatment-with-anlotinib-first-line-ther-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/a-real-world-study-of-optimal-treatment-with-anlotinib-first-line-ther-peer-reviewed-fulltext-article-CMAR

Similar Items